PT Kalbe Farma Tbk. (PTKFF)

Market Cap	4.30B
Revenue (ttm)	2.12B
Net Income (ttm)	203.45M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	21.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	932
Open	0.0951
Previous Close	n/a
Day's Range	0.0951 - 0.0951
52-Week Range	0.0867 - 0.1184
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 14, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the comp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 13,108
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFF

Financial Performance

In 2023, PT Kalbe Farma Tbk.'s revenue was 30.45 trillion, an increase of 5.24% compared to the previous year's 28.93 trillion. Earnings were 2.77 trillion, a decrease of -18.20%.

Financial numbers in IDR